Global Mandibular-Advancement-Device Market

Market Overview

The global Mandibular Advancement Device (MAD) Market is expanding as awareness of obstructive sleep apnea (OSA) increases and patients seek comfortable, non-invasive alternatives to conventional positive airway pressure therapy. IMARC estimates the global market at USD 822.3 million in 2025, reaching USD 1.64 billion by 2034 at a CAGR of 7.75%. North America currently dominates due to established sleep-medicine infrastructure, high awareness, and strong adoption of oral appliances. Custom-fitted devices are particularly important because they can be designed around individual dentition and adjusted during treatment; Mordor Intelligence reports custom devices held 56.76% revenue share in 2025. The market is benefiting from digital dental workflows, intraoral scanning, 3D printing, remote monitoring, improved device comfort, and increasing recognition of MADs for patients with mild-to-moderate OSA and those unable to tolerate CPAP.

Market Value Snapshot

Metric	Market Insight
Market Size, 2025	USD 822.3 Million
Market Forecast, 2034	USD 1.64 Billion
CAGR	7.75%
Leading Product	Custom MAD
Leading Application	Obstructive Sleep Apnea
Leading Material	Plastic / Polymer
Leading Region	North America
Key Growth Theme	Digital Customization & Non-Invasive OSA Treatment
Major Companies	ResMed, SomnoMed, ProSomnus, Vivos Therapeutics, Panthera Dental, DynaFlex

Key Market Factors

• Trend: MAD development is shifting toward digitally designed and manufactured appliances, intraoral scanning, precision adjustment, 3D printing, and integrated physiologic monitoring. Custom devices accounted for 56.76% of revenue in 2025 in one recent assessment.
• Driver: Rising OSA awareness, demand for non-invasive treatment, CPAP intolerance, improved dental-sleep medicine awareness, and better-fitting appliances are supporting market adoption.
• Challenge: Reimbursement differences, clinical evidence requirements, dental-provider availability, patient fit and comfort, jaw-related side effects, and the need for professional fitting can limit adoption across some markets.
• Opportunity: Connected oral appliances, remote physiologic monitoring, AI-assisted titration, digital dental laboratories, 3D printing, pediatric applications, and personalized device platforms are creating new opportunities for manufacturers.

Regional Outlook

North America: North America remains the leading regional market, supported by high OSA awareness, developed sleep clinics and dental networks, established reimbursement pathways, and strong adoption of prescription oral appliances. Mordor Intelligence estimates the region represented 43.21% of global revenue in 2025.

Europe: European demand is supported by sleep-disorder diagnosis, dental sleep medicine, healthcare modernization, and increasing interest in alternatives to PAP therapy. Digital dental manufacturing and customized appliance production are strengthening the regional ecosystem.

Asia Pacific: Asia Pacific is expected to record strong growth as awareness of sleep apnea increases, healthcare infrastructure expands, and dental technologies become more accessible. Mordor Intelligence identifies Asia Pacific as the fastest-growing major region, with a projected 8.54% CAGR through 2031.

Latin America: Brazil, Mexico, Argentina, Colombia, and Chile offer opportunities through expanding private healthcare, dental clinics, sleep diagnostics, and growing awareness of untreated sleep-disordered breathing.

Middle East & Africa: Growth is supported by expanding specialty healthcare infrastructure, private dental services, sleep clinics, and increasing availability of advanced oral appliances.

Types

• Custom-Fit Mandibular Advancement Devices
• Semi-Custom MADs
• Non-Custom MADs
• Bite MADs
• Monoblock MADs
• Dual-Block MADs
• Adjustable MADs
• Titratable MADs
• Fixed MADs
• Digital MADs
• 3D-Printed MADs
• Metal-Component MADs
• Polymer MADs
• Thermoplastic MADs
• Pediatric MADs
• Prescription MADs
• Clinician-Fitted MADs
• Removable MADs
• Low-Profile MADs
• Advanced Precision MADs

Applications

• Obstructive Sleep Apnea
• Mild-to-Moderate OSA
• Primary Snoring
• Sleep-Disordered Breathing
• Upper-Airway Obstruction
• Bruxism
• Temporomandibular Joint-Related Applications
• Adult Sleep Medicine
• Pediatric Sleep Medicine
• Home Sleep Therapy
• Dental Sleep Medicine
• CPAP-Intolerant Patients
• CPAP-Non-Compliant Patients
• Combination Sleep Therapy
• Sleep Clinic Treatment
• Dental Clinic Treatment

Recent Activities & Developments

The market is increasingly combining oral appliance therapy with digital dentistry and remote monitoring. Custom appliances can now be developed through digital impressions, computer-aided design, automated manufacturing, and 3D printing, enabling more precise fitting and repeatable production. Mordor Intelligence identifies digital manufacturing as an important development affecting both appliance design and dental laboratory workflows.

Connected monitoring represents another emerging direction. In April 2026, ProSomnus received FDA Class II 510(k) clearance for its RPMO₂ OSA Device, combining a precision oral appliance with an embedded oximeter capable of collecting multi-night oxygen saturation and pulse-rate data and transmitting information through a provider platform. This development points toward a broader shift from passive oral appliances toward data-enabled sleep therapy.

Regulatory activity also continues to shape the market. In March 2026, the FDA cleared the ShaeferH Oral Sleep Appliance as a prescription, custom-fabricated mandibular advancement device for adults with mild-to-moderate OSA and/or snoring. At the same time, regulatory oversight remains important: the FDA classifies intraoral devices for snoring and OSA as removable medical devices and provides specific regulatory guidance for this product category.

The competitive landscape includes ResMed, SomnoMed, ProSomnus Sleep Technologies, Panthera Dental, Vivos Therapeutics, DynaFlex, Glidewell, NDX Keller Dental Lab, The Aurum Group, Apnea Sciences, Erkodent, OSCIMED, and Scheu-Dental. Vivos also announced a new U.S. patent in August 2026 broadening protection around its oral medical-device technology involving mandibular advancement.

Overall, the global Mandibular Advancement Device market is moving toward customized digital fabrication, precision titration, connected monitoring, clinician-guided therapy, and personalized sleep medicine, positioning MADs as an increasingly important non-invasive treatment option within the expanding OSA care ecosystem.